Specific claims:

- The US pays more for new drugs than the rest of the world

- The US contribution is disproportionate, and is major driver of the drug development industry.

-If the US paid less for new drugs, the entire industry would slow, and we would have fewer more effective treatments.

...

Routine medical procedures being crazy expensive is unrelated and pathological.